Windtree Therapeutics Inc... (WINT)
NASDAQ: WINT
· Real-Time Price · USD
0.51
-0.01 (-1.28%)
At close: Aug 15, 2025, 3:57 PM
0.51
-1.07%
After-hours: Aug 15, 2025, 07:58 PM EDT
Windtree Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -16.05M | -1.79M | -9.71M | -11.38M | -5.96M | -20.29M | -24.83M | -24.46M | -35.19M | -39.21M | -42.59M | -46.75M | -66.8M | -67.64M | -62.02M | -62.82M | -34.99M |
Depreciation & Amortization | 80K | 84K | 399K | 382K | 389K | 391K | 393K | 304K | 90K | 533K | 561K | 587K | 613K | 192K | 182K | 176K | 168K |
Stock-Based Compensation | 276K | 455K | 740K | 959K | 1.24M | 1.28M | 1.76M | 2.2M | 2.6M | 3.09M | 3.92M | 4.8M | 5.57M | 7.24M | 6.9M | 6.42M | 6.44M |
Other Working Capital | 251K | 301K | 353K | 2.11M | 1.61M | 1.46M | -249K | -843K | -1.38M | -1.33M | -138K | 878K | 525K | 410K | -37K | -906K | -137K |
Other Non-Cash Items | -839K | -15.53M | -8.18M | -6.77M | -12.08M | 3.17M | 10.51M | 10.78M | 19.96M | 19.28M | 19.07M | 19.13M | 7.76M | 8.49M | 937K | 947K | 2.07M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -1.37M | -1.37M | -1.37M | -1.37M | -1.66M | -1.62M | 28.22M | 28.11M | 30.91M | 30.88M | 1.03M |
Change in Working Capital | 1.67M | 1.37M | 1.46M | 4.12M | 2.54M | 2.02M | 285K | -951K | -1.35M | -1.78M | -310K | 1.66M | 310K | -58K | -181K | -1.84M | -599K |
Operating Cash Flow | -14.86M | -15.4M | -15.28M | -12.69M | -13.87M | -13.44M | -13.25M | -13.49M | -15.26M | -19.45M | -21M | -22.19M | -24.33M | -23.66M | -23.27M | -26.25M | -25.88M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10K | -13K | -186K | -289K | -282K | -279K | -370K | -282K | -291K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 210K | 210K | 210K | 210K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 210.00 | 210.00 | 210.00 | 210.00 | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | -15K | -15K | -15K | -15K | n/a | 200K | 197K | 24K | -79K | -282K | -279K | -370K | -282K | -291K |
Debt Repayment | 1.57M | 1.26M | 934K | 962K | -778K | -797K | -563K | -330K | -252K | -294K | -294K | -734K | -3.37M | -3.43M | -3.78M | -6.99M | -4.35M |
Common Stock Repurchased | -1.51M | -1.03M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | -400K | -310K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 9.72M | 7.33M | -1.26M | -168K | -100K | 843K | 466K | 88K | -37K | -675K | -539K | 239K | 764K | 559K | 1.2M | 3.31M | 3.91M |
Financial Cash Flow | 13.5M | 12.73M | 10.09M | 2.92M | 12.04M | 11.6M | 12.19M | 13.58M | 3.76M | 3.08M | 4.88M | 3.68M | 1.66M | 29.36M | 26.5M | 25.4M | 47.77M |
Net Cash Flow | -1.37M | -2.68M | -5.21M | -9.8M | -1.84M | -1.86M | -1.07M | 85K | -11.3M | -16.18M | -16.11M | -18.59M | -22.95M | 5.42M | 2.19M | -1.55M | 21.69M |
Free Cash Flow | -14.87M | -15.41M | -15.3M | -12.72M | -13.88M | -13.45M | -13.27M | -13.49M | -15.27M | -19.46M | -21.19M | -22.48M | -24.61M | -23.94M | -23.64M | -26.53M | -26.17M |